Inhibitex to Host Conference Call to Report Fourth Quarter and Year End 2008 Financial Results on March 13, 2009

Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host a conference call on Friday, March 13, 2009 at 9:00 a.m. EDT to review the Company�s fourth quarter and year ended December 31, 2008 financial results and provide an update on recent corporate developments. The Company will issue a press release regarding its financial results on the same day, prior to the conference call.

Webcast Information

To access the conference call, please dial 877-407-8033 (domestic) or 201-689-8033 (international). A replay of the call will be available from 11:00 a.m. EDT on March 13 until April 13, 2009 at midnight. To access the replay, please dial 877-660-6853 (domestic) or 201-612-7415 (international) and reference the account # 286 and the conference id # 316302. A live audio webcast of the call and the archived webcast will be available in the News and Events section of the Inhibitex website at http://www.inhibitex.com.

About Inhibitex

Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company focused on developing products to treat and prevent serious infectious diseases. The Company�s pipeline includes FV-100, its clinical-stage oral nucleoside analogue in development for the treatment of herpes zoster (shingles), as well as a series of HCV nucleoside polymerase inhibitors and HIV integrase inhibitors. Inhibitex has also licensed certain of its proprietary MSCRAMM� protein technology to Wyeth for the development of staphylococcal vaccines.

For additional information about the Company, please visit www.inhibitex.com.

Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024